ImmunityBio

Últimas notícias

Manchetes no idioma original da fonte.

• Sellas Life Sciences and ImmunityBio Stocks Rise Amid Moderna's Nasdaq-100 Entry (abre em uma nova aba)

  SuaraGarut.ID · 2 de out. de 2026

• SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot (abre em uma nova aba)

  Asianet Newsable · 2 de out. de 2026

• 2026 Biotech Watchlist IBRX, PACB, IGC, VIVS Lead 7 Stocks in Focus (abre em uma nova aba)

  FinancialContent · 2 de out. de 2026

• How High Can IBRX Stock Go Now? Here’s What Wall Street Thinks After Saudi Nod For Bladder Cancer Filing (abre em uma nova aba)

  Stocktwits · 1 de out. de 2026

• IBRX Stock Climbs Premarket Despite Investor Stake Cut — Retail Sees ‘Imminent’ Global Rollout Catalyst (abre em uma nova aba)

  Stocktwits · 1 de out. de 2026

• ImmunityBio Stock Analysis: Bullish Breakout in October (abre em uma nova aba)

  The Cryptonomist · 1 de out. de 2026

• IBRX Stock Racks Up 3 Straight Quarterly Wins: Q3 Filings Reveal BlackRock Closing In On Vanguard With A Bigger Bet (abre em uma nova aba)

  TradingView · 1 de out. de 2026

• The Secret Biotech Billionaire Behind ImmunityBio (IBRX) Revealed Brandon Valenzuela (TprKjgKx9D) (abre em uma nova aba)

  media.unisba.ac.id · 30 de set. de 2026

• IBRX Stock Holds Gains As Soon‑Shiong Expands Oncology Network (abre em uma nova aba)

  StocksToTrade · 30 de set. de 2026

• ImmunityBio Stock Analysis: Bullish Trend Today with Key Resistance (abre em uma nova aba)

  The Cryptonomist · 30 de set. de 2026

• IBRX Breaks Above This Key Resistance — Stock On Track To Record Best Single-Day Gains In 6 Months (abre em uma nova aba)

  Asianet Newsable · 30 de set. de 2026

• ImmunityBio Soars After Key Breakout Spurs Biotech Buzz (abre em uma nova aba)

  tipranks.com · 30 de set. de 2026

• ImmunityBio Shares Rise as Investors Revisit ANKTIVA Expansion and Revenue Momentum (abre em uma nova aba)

  Quiver Quantitative · 30 de set. de 2026

• Immunitybio Inc Stock (IBRX) Moved Up by 11.15% on Sep 30: What Signal Does It Send? (abre em uma nova aba)

  TradingKey · 30 de set. de 2026

• IBRX Stock Grinds Higher As Chairman Expands Oncology Reach (abre em uma nova aba)

  StocksToTrade · 30 de set. de 2026

• Midday Movers: ImmunityBio and United Therapeutics Lead Gains as Liquidia Tumbles (abre em uma nova aba)

  Business Upturn · 30 de set. de 2026

• ImmunityBio Stock Soars 11% as Anktiva Momentum and FDA Catalyst Hopes Fuel Rally in Soon-Shiong's Biotech (abre em uma nova aba)

  International Business Times Australia · 30 de set. de 2026

• A $5.8B Cancer Market Opportunity Is Emerging — Why GA-Courtenay Favors ImmunityBio (IBRX) (abre em uma nova aba)

  Yahoo Finance · 30 de set. de 2026

• Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump? (abre em uma nova aba)

  es.tradingview.com · 30 de set. de 2026

• ImmunityBio’s Q4 Revenue Gets A Lift From ANKTIVA Sales – IBRX Stock Gains 11% (abre em uma nova aba)

  Stocktwits · 30 de set. de 2026

• ImmunityBio: IBRX Stock Is Up 225% And It’s Just The Beginning! ($24 Target?) Jesper Wallstedt (k7jZus2cwY) (abre em uma nova aba)

  media.unisba.ac.id · 29 de set. de 2026

• ImmunityBio Inc Revenue Breakdown – HAN:26CA (abre em uma nova aba)

  TradingView · 29 de set. de 2026

• ImmunityBio Soars as Speculation Ignites Retail Frenzy (abre em uma nova aba)

  tipranks.com · 28 de set. de 2026

• IBRX Founder Backs Trump’s Psychedelic Push In ‘Transforming’ Health Policy — Flags New Anktiva Breast Cancer Risk Data (abre em uma nova aba)

  Stocktwits · 27 de set. de 2026

• IMMUNITYBIO INC (IBRX) Stock Chart (abre em uma nova aba)

  ChartMill · 26 de set. de 2026

• ImmunityBio, Inc. Tokenized Stock (Robinhood) to United States Dollar Price Today | Live IBRX to USD Converter & Exchange Rate (abre em uma nova aba)

  CryptoRank · 25 de set. de 2026

• Is ImmunityBio (IBRX) A Bargain As Turkey Expansion Fuels Fresh Growth Hopes? (abre em uma nova aba)

  Simply Wall Street · 25 de set. de 2026

• ImmunityBio Stock Sinks as Speculative Rally Unravels (abre em uma nova aba)

  tipranks.com · 23 de set. de 2026

• ImmunityBio Advances Patient-Centric Clinical Trial Design in Bladder Cancer (abre em uma nova aba)

  Oncodaily · 23 de set. de 2026

• Could Tokenized Trading Change The Case For ImmunityBio Stock (abre em uma nova aba)

  Simply Wall Street · 23 de set. de 2026